References
- Kim, James and Anthony Scialli, Thalidomide: The Tragedy of Birth Defects and the Effective Treatment of Disease. 122(1); 1-6.
- J. Botting, The History of Thalidomide, Drug News Perspect. 2002; 15(9); 604-611 & The Guardian (2012), http://www.theguardian.com/society/2012/sep/01/thalidomide-scandal-timeline
- J. Botting, The History of Thalidomide, Drug News Perspect. 2002; 15(9); 604-611
- The Guardian (2012), http://www.theguardian.com/society/2012/sep/01/thalidomide-scandal-timeline & Robert McFadden for The New York Times (2015), Frances Oldham Kelsey, Who Saved U.S. Babies from Thalidomide, Dies at 101 http://www.nytimes.com/2015/08/08/science/frances-oldham-kelsey-fda-doctor-who-exposed-danger-of-thalidomide-dies-at-101.html?_r=0
- nlm.nih.gov, 2015 https://www.nlm.nih.gov/changingthefaceofmedicine/physicians/biography_182.html
- The Guardian (2012), http://www.theguardian.com/society/2012/sep/01/thalidomide-scandal-timeline
- Robert McFadden for The New York Times (2015), Frances Oldham Kelsey, Who Saved U.S. Babies from Thalidomide, Dies at 101 http://www.nytimes.com/2015/08/08/science/frances-oldham-kelsey-fda-doctor-who-exposed-danger-of-thalidomide-dies-at-101.html?_r=0 & Rodin, A.E. et al (1962) Case report: Association of Thalidomide (Kevadon) with Congenital Anomalies. Canad. Med. Ass. J. April 21, 1962, Vol. 86; 744-746.
- Ingrid Peritz for The Globe and Mail, August 15, 2015
- https://www.mcgill.ca/about/history/features/mcgill-women
- Harris, Gardiner for the NYTimes, September 13, 2010. The Public's Quiet Savior from Harmful Medicines http://www.nytimes.com/2010/09/14/health/14kelsey.html; Bernstein, Adam and Patricia Sullivan for the Washington Post, August 7, 2015. Frances Oldham Kelsey, FDA Scientist who kept thalidomide off U.S. market, dies at 101 https://www.washingtonpost.com/national/health-science/frances-oldham-kelsey-heroine-of-thalidomide-tragedy-dies-at-101/2015/08/07/ae57335e-c5da-11df-94e1-c5afa35a9e59_story.html
- Robert McFadden for The New York Times (2015), Frances Oldham Kelsey, Who Saved U.S. Babies from Thalidomide, Dies at 101 http://www.nytimes.com/2015/08/08/science/frances-oldham-kelsey-fda-doctor-who-exposed-danger-of-thalidomide-dies-at-101.html?_r=0
- Kuehn, Bridget M. JAMA November 17, 2010, Medical News and Perspectives; 304(19), pp 2109-2112.
- Kuehn, Bridget M. JAMA November 17, 2010, Medical News and Perspectives; 304(19), pp 2109-2112.
- Kuehn, Bridget M. JAMA November 17, 2010, Medical News and Perspectives; 304(19), pp 2109-2112.
- Kuehn, Bridget M. JAMA November 17, 2010, Medical News and Perspectives; 304(19), pp 2109-2112.
- http://helix.northwestern.edu/article/thalidomide-tragedy-lessons-drug-safety-and-regulation
- U.S. Food and Drug Administration, Kefauver-Harris Amendments Revolutionized Drug Development http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm322856.htm
- Kuehn, Bridget M. JAMA November 17, 2010, Medical News and Perspectives; 304(19), pp 2109-2112 & U.S. Food and Drug Administration, Kefauver-Harris Amendments Revolutionized Drug Development http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm322856.htm
- U.S. Food and Drug Administration, Kefauver-Harris Amendments Revolutionized Drug Development http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm322856.htm
- U.S. Food and Drug Administration, Kefauver-Harris Amendments Revolutionized Drug Development http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm322856.htm
- U.S. Food and Drug Administration, Kefauver-Harris Amendments Revolutionized Drug Development http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm322856.htm
- Kuehn, Bridget M. JAMA November 17, 2010, Medical News and Perspectives; 304(19), pp 2109-2112 & U.S. Food and Drug Administration, Kefauver-Harris Amendments Revolutionized Drug Development http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm322856.htm
- Harris, Gardiner for the NYTimes, September 13, 2010. The Public's Quiet Savior from Harmful Medicines http://www.nytimes.com/2010/09/14/health/14kelsey.html;
- Kuehn, Bridget M. JAMA November 17, 2010, Medical News and Perspectives; 304(19), pp 2109-2112